InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

Current share price for CYP : $0.012 0.001 (7.69%)+

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Appendix 3B 16 Dec 2015 7:21PM $0.340 $0.012 fallen by 96.47%
$3 Rodman & Renshaw Initiates Cynata Research Coverage 8 Dec 2015 10:39AM $0.370 $0.012 fallen by 96.76%
$3 CYP Enters Letter of Intent for Strategic Alliance in Japan 3 Dec 2015 9:25AM $0.400 $0.012 fallen by 97%
$3 Expiry of Unlisted Options 1 Dec 2015 9:22AM $0.390 $0.012 fallen by 96.92%
$3 Results of Annual General Meeting 11 Nov 2015 1:39PM $0.440 $0.012 fallen by 97.27%
$3 MD's AGM Presentation 11 Nov 2015 12:25PM $0.435 $0.012 fallen by 97.24%
$3 Restricted Securities to be Release from Escrow 6 Nov 2015 4:42PM $0.425 $0.012 fallen by 97.18%
$3 Cynata Engages CRO to Conduct GvHD Clinical Trial 5 Nov 2015 9:40AM $0.440 $0.012 fallen by 97.27%
$3 Activities Report & Appendix 4C 29 Oct 2015 5:55PM $0.430 $0.012 fallen by 97.21%
$3 CYP in Major New Collaboration for Cell Therapy for Cancer 14 Oct 2015 9:15AM $0.420 $0.012 fallen by 97.14%
$3 Annual Report to Shareholders 6 Oct 2015 4:48PM $0.470 $0.012 fallen by 97.45%
$3 Notice of Annual General Meeting/Proxy Form 6 Oct 2015 4:43PM $0.470 $0.012 fallen by 97.45%
$3 Cynata to Present at Rodman & Renshaw Investment Conference 7 Sep 2015 9:44AM $0.540 $0.012 fallen by 97.78%
$3 SeeThruEquity Initiates Cynata Reasearch Coverage 3 Sep 2015 10:27AM $0.490 $0.012 fallen by 97.55%
$3 Appendix 4G 21 Aug 2015 4:26PM $0.590 $0.012 fallen by 97.97%
$3 Appendix 4E & FInancial Statements 21 Aug 2015 4:24PM $0.590 $0.012 fallen by 97.97%
$3 Activities Report & Appendix 4C 30 Jul 2015 3:12PM $0.690 $0.012 fallen by 98.26%
$3 Cynata in Heart Disease Collaboration with Uni of Sydney 30 Jul 2015 9:52AM $0.685 $0.012 fallen by 98.25%
$3 Information Required Under Listing Rule 3.10.5A 17 Jul 2015 5:09PM $0.750 $0.012 fallen by 98.40%
$3 Section 708A Notice 17 Jul 2015 5:08PM $0.750 $0.012 fallen by 98.40%
$3 Appendix 3B 17 Jul 2015 5:07PM $0.750 $0.012 fallen by 98.40%
$3 Section 708A Notice 15 Jul 2015 10:19AM $0.870 $0.012 fallen by 98.62%
$3 Private Placement to US Institutional Investors Completed 15 Jul 2015 9:52AM $0.870 $0.012 fallen by 98.62%
$3 R&D Tax Incentive 25 May 2015 8:35AM $0.940 $0.012 fallen by 98.72%
$3 Cynata - Cymerus Progress Report 21 May 2015 9:03AM $1.070 $0.012 fallen by 98.88%

651 - 675 of 699 results

Page 27 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.